Table 3.

H. pylori Eradication Rates with Physician-selected Standard-of-Care (mITT).

	Placebo	RHB-105 Treatment Failures	Total
All Subjects	17/27 (62.9%)	2/4 (50.0%)	19/31 (61.3%)
Clarithromycin triple therapy a	14/23 (60.9%)	2/4 (50.0%)	16/27 (59.3%)
Metronidazole triple therapy b	1/2 (50.0%)	0	1/2 (50.0%)
Bismuth quadruple therapy c	2/2 (100.0%)	0	2/2 (100.0%)

mITT = modified intent-to-treat. ^a Clarithromycin, amoxicillin, and proton pump inhibitor (omeprazole or lansoprazole). ^b Metronidazole, bismuth subcitrate potassium, and tetracycline. ^c Bismuth subcitrate potassium, metronidazole, tetracycline, and omeprazole.